# Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Study · id `cardio:ct-nct04088292` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04088292](<https://clinicaltrials.gov/study/NCT04088292>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04088292

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 210 participants.

## Technical summary

Registry record NCT04088292. Randomized; single masking; primary purpose treatment. Start 2019-06-06 (actual); primary completion 2024-06-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT04088292, source copy `cardio:ctgov-nct04088292-2024-11-15`, retrieved 2026-10-31)
- Started: 2019-06-06 (actual) (ClinicalTrials.gov record NCT04088292, source copy `cardio:ctgov-nct04088292-2024-11-15`, retrieved 2026-10-31)
- Primary completion: 2024-06-05 (actual) (ClinicalTrials.gov record NCT04088292, source copy `cardio:ctgov-nct04088292-2024-11-15`, retrieved 2026-10-31)
- Completion: 2024-11-30 (anticipated) (ClinicalTrials.gov record NCT04088292, source copy `cardio:ctgov-nct04088292-2024-11-15`, retrieved 2026-10-31)
- Countries: Denmark (ClinicalTrials.gov record NCT04088292, source copy `cardio:ctgov-nct04088292-2024-11-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04088292-2024-11-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
- Acronym: STRATIFY
- Condition: Pulmonary Embolism
- Intervention (Drug): Alteplase 20 Mg Powder for Solution for Injection Vial
- Intervention (Device): Ultrasound assisted Thrombolysis
- Lead sponsor: Copenhagen University Hospital, Rigshospitalet
- Lead sponsor class: OTHER
- Collaborator: Herlev and Gentofte Hospital
- Collaborator class: OTHER
- Collaborator: University Hospital Bispebjerg and Frederiksberg
- Collaborator class: OTHER
- Collaborator: Hillerod Hospital, Denmark
- Collaborator class: OTHER
- Collaborator: Copenhagen University Hospital, Hvidovre
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)
- Registry lists this organization as a collaborator: Herlev and Gentofte Hospital (`cardio:org-herlev-and-gentofte-hospital`)
- Registry lists this organization as a collaborator: University Hospital Bispebjerg and Frederiksberg (`cardio:org-university-hospital-bispebjerg-and-frederiksberg`)
- Registry lists this organization as a collaborator: Hillerod Hospital, Denmark (`cardio:org-hillerod-hospital-denmark`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized trial of low-dose, ultrasound-assisted thrombolysis or heparin for pulmonary embolism (`cardio:pubmed-41610160`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8eaf57b75cfffaed65e288d06627886e0f0b398354113717be0a6adc61dd54fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
